58 related articles for article (PubMed ID: 15610570)
21. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
Stephenson AJ; Sheinfeld J
Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
[TBL] [Abstract][Full Text] [Related]
22. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
[TBL] [Abstract][Full Text] [Related]
23. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
24. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy for stage II nonseminomatous testicular cancer: what is its role?
Motzer RJ
Semin Urol Oncol; 1996 Feb; 14(1):30-3. PubMed ID: 8833386
[TBL] [Abstract][Full Text] [Related]
26. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
27. Management of the post-chemotherapy residual mass in patients with advanced stage non-seminomatous germ cell tumors (NSGCT).
Kuczyk M; Machtens S; Stief C; Jonas U
Int J Cancer; 1999 Dec; 83(6):852-5. PubMed ID: 10597210
[TBL] [Abstract][Full Text] [Related]
28. An unusual late relapse in pathologic stage I non-seminomatous germ cell tumor: case report and review of the literature.
Bilgrami S; Chen L; Shafi N; Synnott V; Greenberg B
Urol Int; 1994; 53(3):176-8. PubMed ID: 7544042
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
[TBL] [Abstract][Full Text] [Related]
30. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
[TBL] [Abstract][Full Text] [Related]
31. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
Heidenreich A; Thüer D; Polyakov S
Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
[TBL] [Abstract][Full Text] [Related]
32. Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.
Donohue JP; Fox EP; Williams SD; Loehrer PJ; Ulbright TM; Einhorn LH; Weathers TD
World J Urol; 1994; 12(4):190-5. PubMed ID: 7820140
[TBL] [Abstract][Full Text] [Related]
33. Primary treatment in stage II non-seminomatous germ cell tumours of the testis: a matter of scalpel or drug infusion?
Culine S; Droz JP
Eur J Cancer; 1996 Sep; 32A(10):1641-4. PubMed ID: 8983268
[TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors.
Fernandez EB; Moul JW; Foley JP; Colon E; McLeod DG
Urology; 1994 Oct; 44(4):548-52. PubMed ID: 7941194
[TBL] [Abstract][Full Text] [Related]
35. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy.
Baniel J; Sella A
Semin Surg Oncol; 1999 Dec; 17(4):263-7. PubMed ID: 10588855
[TBL] [Abstract][Full Text] [Related]
36. Peri-operative care in patients treated for testicular cancer.
Donat SM
Semin Surg Oncol; 1999 Dec; 17(4):282-8. PubMed ID: 10588858
[TBL] [Abstract][Full Text] [Related]
37. Stage II nonseminomatous testis cancer: the roles of primary and adjuvant chemotherapy.
Frohlich MW; Small EJ
Urol Clin North Am; 1998 Aug; 25(3):451-9. PubMed ID: 9728214
[TBL] [Abstract][Full Text] [Related]
38. Retroperitoneal lymphadenectomy in staging and treatment of clinical stage I and II nonseminomatous testis cancer (NSGCT): the development of nerve-sparing techniques.
Donohue JP
Cancer Treat Res; 1996; 88():105-19. PubMed ID: 9239475
[No Abstract] [Full Text] [Related]
39. The current role of surgery in the management of residual disease.
Christmas TJ; Mannion EM; Bower M
Curr Opin Urol; 1999 Sep; 9(5):439-42. PubMed ID: 10579083
[TBL] [Abstract][Full Text] [Related]
40. Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer.
Mittakanti HR; Porter JR
Transl Androl Urol; 2020 Jan; 9(Suppl 1):S66-S73. PubMed ID: 32055487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
